The future of medicine lies in reprogramming the body to repair itself. We design the models and the medicines to teach it how. Backed by True Ventures.
About the role
We are seeking a highly capable and proactive Senior T Cell Immunologist to join our Boston team, reporting into the Head of Innovation Science. This role will own the biology behind our in vivo cell therapy programs in oncology and autoimmunity, from primary human cell assays through IND-enabling studies. Found on 1752vc Careers, the job board for startup and VC roles.
What they're looking for
- Deep hands-on expertise in primary human T cell biology: isolation, activation, expansion, transfection and transduction, and functional characterization
- Experience with gene editing in primary immune cells (nucleases, base or prime editors, transposons, recombinases/integrases, or equivalent), including how editing outcomes are measured
- Expertise in multiparameter flow cytometry using antibody panels and fluorescent reporters, including panel design and analysis
- Fluency with ddPCR, qPCR, NGS library preparation and QC, and interpretation of on/off-target analytics
- Experience designing and overseeing in vivo mouse studies, including CRO management
- Excellent communication skills with internal and external stakeholders
More about this role
Basecamp Research is building frontier AI for therapeutic design. We believe the future of medicine lies in reprogramming the body to repair itself, and we design the models and the medicines to teach it how.
Our EDEN models are trained on BaseData, the world's largest proprietary genomic dataset, with over 10B genes collected through partnerships in more than 30 countries across all seven continents. This gives our AI models access to genetic diversity that doesn't exist in public databases, and enables EDEN to design cell and gene therapies, enzymes, and peptides directly from information about a disease. Our pipeline of EDEN-designed therapeutics, beginning with in vivo cell therapy, is advancing towards clinical development.
In September 2026 we closed an oversubscribed $140M Series C led by S32, with participation from NVIDIA, Anthropic's Anthology Fund, Catalio, European Tech Collective, Firebrand River Capital, King Philanthropies, NATO Innovation Fund, NVentures (NVIDIA's venture arm), Redalpine, Rockefeller Foundation, Singular, Sovereign AI and True Ventures. We have offices and labs in London and Boston, we partner with biopharma companies and academic institutions...
Browse similar: Startup jobs